Mucin 1 deficiency mediates corticosteroid insensitivity in asthma
Impacto
Scholar |
Otros documentos de la autoría: MILARA, JAVIER; Morell, Anselm; de Diego, Alfredo; Artigues, Enrique; Morcillo, Esteban; Cortijo, Julio
Metadatos
Mostrar el registro completo del ítemcomunitat-uji-handle:10234/9
comunitat-uji-handle2:10234/36080
comunitat-uji-handle3:10234/36082
comunitat-uji-handle4:
INVESTIGACIONEste recurso está restringido
https://doi.org/10.1111/all.13546 |
Metadatos
Título
Mucin 1 deficiency mediates corticosteroid insensitivity in asthmaAutoría
Fecha de publicación
2019-01Editor
WileyISSN
0105-4538; 1398-9995Cita bibliográfica
MILARA, Javier, et al. Mucin 1 deficiency mediates corticosteroid insensitivity in asthma. Allergy, 2019, vol. 74, no 1, p. 111-121Tipo de documento
info:eu-repo/semantics/articleVersión de la editorial
https://onlinelibrary.wiley.com/doi/abs/10.1111/all.13546Versión
info:eu-repo/semantics/publishedVersionPalabras clave / Materias
Resumen
BACKGROUND:
The loss of corticosteroid efficacy is an important issue in severe asthma management and may lead to poor asthma control and deterioration of airflow. Recent data indicate that Mucin 1 (MUC1) membrane ... [+]
BACKGROUND:
The loss of corticosteroid efficacy is an important issue in severe asthma management and may lead to poor asthma control and deterioration of airflow. Recent data indicate that Mucin 1 (MUC1) membrane mucin can mediate corticosteroid efficacy in chronic rhinosinusitis, but the role of MUC1 in uncontrolled severe asthma is unknown. The objective was to analyze the previously unexplored role of MUC1 on corticosteroid efficacy in asthma.
METHODS:
Mucin 1 expression was evaluated by real-time PCR in human bronchial epithelial cells (HBEC) and blood neutrophils from uncontrolled severe asthma (n = 27), controlled mild asthma (n = 16), and healthy subjects (n = 13). IL-8, MMP9, and GM-CSF were measured by ELISA in HBEC and neutrophils. An asthma model of ovalbumin (OVA) was used in MUC1 KO and WT C57BL/6 mice according to ARRIVE guidelines.
RESULTS:
Mucin 1-CT expression was downregulated in bronchial epithelial cells and peripheral blood neutrophils from severe asthma patients compared with mild asthma and healthy subjects (P < 0.05). Daily dose of inhaled corticosteroids (ICS) inversely correlated with MUC1 expression in neutrophils from mild and severe asthma (ρ = -0.71; P < 0.0001). Dexamethasone showed lower anti-inflammatory effects in severe asthma peripheral blood neutrophils and HBECs stimulated with lipopolysaccharide (LPS) than in cells from mild asthma. Glucocorticoid receptor (GR)-α phosphorylated at serine 226 was increased in cells from severe asthma, and the MUC1-CT/GRα complex was downregulated in severe asthma cells. OVA asthma model in MUC1 KO mice was resistant to the anti-inflammatory effects of dexamethasone.
CONCLUSION:
Mucin 1-CT modulates corticosteroid efficacy in vitro and in vivo asthma models. [-]
Publicado en
Allergy, 2019, vol. 74, no 1Proyecto de investigación
Ministerio de Ciencia e Innovacion: SAF2015-65368-R; SAF2017-82913-R; TRA2009-0311; Instituto de Salud Carlos III: CB06/06/0027; FIS PI14/01733; FIS PI17/02158; GOBIERNO REGIONAL COMUNIDAD VALENCIANA: Prometeu/2017/023/UVDerechos de acceso
© EAACI and John Wiley and Sons A/S. Published by John Wiley and Sons Ltd.
http://rightsstatements.org/vocab/InC/1.0/
info:eu-repo/semantics/restrictedAccess
http://rightsstatements.org/vocab/InC/1.0/
info:eu-repo/semantics/restrictedAccess
Aparece en las colecciones
- MED_Articles [639]